Global Infectious Disease Point of Care Diagnostics Market was Valued at US$ XX Mn in 2018, High Prevalence of Infectious Diseases in Developing Countries
Analyst Speak:

“The Global Infectious Disease Point of Care Diagnostics Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR over next seven years 2019-2025 due to high prevalence of infectious diseases in developing countries”

The global infectious disease point of care diagnostics market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Some of the key factors fostering the market growth include rising preference for home healthcare across the globe, increasing prevalence of infectious diseases, growing healthcare expenditure, high prevalence of infectious diseases in developing countries, emergence of electronic medical records (EMR) usage with point of care (POC) diagnostics and increasing number of initiatives by various governments and government associations. However, stringent and time-consuming regulatory policies are the key factors hindering the market growth

Global infectious disease point of care diagnostics market segmented on the basis of product type, disease condition, prescription mode, end user and region.

Request Sample Report:
https://www.precisionbusinessinsights.com/request-sample?product_id=16253


Haematology Testing Kits dominate the Global Infectious Disease Point of Care Diagnostics Market

Based on product type, global infectious disease point of care diagnostics market is segmented into infectious disease testing kits & reagents, haematology testing kits, urinalysis testing kits and others. Haematology Testing Kits held considerable market growth during estimated period. It is a branch of internal medicine that deals with the physiology, pathology, etiology, diagnosis, treatment, prognosis and prevention of blood-related disorders. Hematologists also focus on lymphatic organs and bone marrow and may diagnose blood count irregularities or platelet irregularities. They are able to treat organs that are fed by blood cells, including the lymph nodes, spleen, thymus and lymphoid tissue.

Asia Pacific Leads the Global Infectious Disease Point of Care Diagnostics market

PBI’s global infectious disease point of care diagnostics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. Asia Pacific accounted for larger revenue share in global infectious disease point of care diagnostics market with considerable CAGR due to increasing awareness about diseases, rising government funding in these countries, large pool of patients and improving healthcare infrastructure. In addition, North America held significant market share during estimated period owing to increasing number of product approvals, and rising government initiatives to support the adoption of POC in this region.

Strategic Approvals are the key strategies adopted by market players

Global infectious disease point of care diagnostics market further reveals that the key players increasingly accepting strategies such as approvals of the new products, launch of newer products, recurrent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the regions. For Instance, In 2014, in the cardiovascular space, Spartan Biosciences had received approval from Health Care Canada for its genetic test, Spartan RX CYP2C19 system.

Key player’s profiles in the report are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), F. Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Quidel Corporation (U.S.).

Precision Business Insights (PBI) in its report titled “Global Infectious Disease Point of Care Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

Detailed Segmentation

By Product Type
o Infectious Disease Testing Kits & Reagents
• Hepatitis
• HIV Infection
• Respiratory Infections
• Influenza
• Sexually-Transmitted Diseases (STDs)
• Others
o Haematology Testing Kits
o Urinalysis Testing Kits
o Others

By Disease Condition
o Bacterial Infections
o Fungal Infections
o Viral Infections
o Cardiovascular Infections
o GI Infections
o Sexually Transmitted Disease
o CNS Infections
o Other

By Prescription Mode
o Over-The-Counter (OTC) Testing Kits
o Prescription-based Testing Kits

By End User
o Professional Diagnostic Centres
• Hospitals
• Outpatient Healthcare Setting
o Homecare
o Others
By Geography
o North America
• US
• Canada
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA




For More Information:
https://www.precisionbusinessinsights.com/market-reports/global-infectious-disease-diagnostics-market/


About Us:
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com